In vitro and in vivo approaches to the characterization of the α1-adrenoceptor

Journal of Autonomic Pharmacology

Volumn 19, Issue 6, 1999, Pages 311-320

  Hudson, A L ^a   Robinson, E S J ^a   Lalies, M D ^a   Tyacke, R J ^a   Jackson, H C ^b   Nutt, D J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 ETHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR; ANTISENSE OLIGONUCLEOTIDE; CLONIDINE; DOPAMINE; EFAROXAN; IDAZOXAN; NORADRENALIN; OXYMETAZOLINE; PRAZOSIN; RADIOLIGAND; RAUWOLSCINE; RECEPTOR SUBTYPE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING KINETICS; BRAIN FUNCTION; FRONTAL CORTEX; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; MICRODIALYSIS; NONHUMAN; PROTEIN LOCALIZATION; RAT; RECEPTOR AFFINITY; RECEPTOR DENSITY; SEPTUM PELLUCIDUM; STRIATE CORTEX;

EID: 0033306302     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2680.1999.tb00003.x     Document Type: Article

References (41)

1. 2-adrenoceptor binding and functíon after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2dihydro-quinoline (EEDQ). Eur. J. Pharmacol., 116, 175-178.
2. 2-adrenoceptors in the central hypotensive effects of imidazoline-like drugs. Ann. N.Y. Acad. Sci., 881, 272-279.
3. 3H]idazoxan in rat brain. J. Pharmacol. Exp. Ther., 241, 1079-1091.
4. 2-Adrenergic Receptors, pp. 179-187. Eds. S.M. Lanier & L.E. Limbird. Harwood, New York.
5. 2-agonist, is mediated in the locus coeruleus in rats. Anaesthesiology, 76, 948-952.
6. DAVIS, R. & WILDE, M.I. (1996). Mirtazapine: a review of its pharmacology and therapeutic potential in the management of major depression. CNS Drugs., 5 (5), 389-402.
7. 2-adrenoceptor antagonists induce behavioural activation in the rat. J. Psychopharmacol., 4, 90-99.
8. DOCHERTY, J.R. (1998). Subtypes of functional alpha1-and alpha2-adrenoceptors. Eur J. Pharmacol., 361, 1-15.
9. EGLEN, R.M., HUDSON, A.L., KENDALL, D.A., NUTT, D.J., MORGAN, N.G., WILSON, V.G. & DILLON, M.P. (1998). 'Seeing through a glass darkly': casting light on imidazoline 'I' sites. Trends Pharmacol. Sci., 19, 381-390.
10. 2 sites in the mammalian central nervous system. Pharmac. Ther., 68, 175-208.
11. GUIMARÃES, S., BRANDAO, F. & PAIVA, M.Q. (1978). A study of the adrenoceptor-mediated feedback mechanisms by using adrenaline as a false transmitter. Naunyn-Schmiedeberg's Arch. Pharmacol., 305, 185-188.
12. GUIMARÃES, S., FIGUEIREDO, I.V., CARAMONA, M.M., MOURA, D. & PAIVA, M.Q. (1998). Prejunctional alpha (2A) -autoreceptors in the human gastric and ileocolic arteries. Naunyn-Schmiedeberg's Arch. Pharmacol., 358 (2), 207-211).
13. HEAL, D.J. (1990). The effects of drugs on noradrenergic behavioural models. In: The Pharmacology of Noradrenaline in the Central Nervous System, pp. 266-315. Eds. D.J. Heal & C.A. Marsden. Oxford University Press, Oxford.
14. 2-adrenoceptors. Pharmacol. Biochem. Behav., 50, 219-224.
15. 2D-subtype. Eur. J. Pharmacol., 277, 215-221.
16. 1-adrenoceptors in the rat brain. Mol. Neuropharmacol., 1, 219-229.
17. 2-adrenoceptors. J. Nuclear Med. Biol., 19, 841-849.
18. 2-adrenoceptor subtypes to the antinociceptive action of dexmedetomidine and clonidine in rodent models of acute and chronic pain. Br. J. Pharmacol., 120 (Suppl.), 229P.
19. 2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmetetomidine in transgenic mice. Br. J. Pharmacol., 122, 1339-1344.
20. 2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur. J. Pharmacol., 372, 31-36.
21. L'HEUREUX, R., DENNIS, T., CURET, O. & SCATTON, B. (1986). Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J. Neurochem., 46, 1794-1801.
22. 2-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion. Mol. Brain Res., 47, 267-274.
23. LU, L. & ORDWAY, G.A. (1997b). alpha(2C)-Adrenoceptors mediate inhibition of forskolin-stimulated cAMP production in rat striatum. Mol. Brain Res., 52, 228-234.
24. 2-Adrenoceptors: more subtypes but fewer functional differences. Trends Pharmacol. Sci., 15, 119-123.
25. MALLARD, N.J., HUDSON, A.L. & NUTT, D.J. (1992). Characterisation and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain. Br. J. Pharmacol., 106, 1019-1027.
26. 2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmetetomidine, in the locus coeruleus of the rat. J. Clin. Invest., 98, 1076-1080.
27. NICHOLAS, A.P., HOKFELT, T. & PIERIBONE, V.A. (1996). The distribution and significance of CNS adrenoceptors examined with in-situ hybridization. Trends Pharmacol. Sci., 17, 245-255.
28. 2-adrenoceptors and blood pressure regulation in the rat. Eur. J. Pharmacol., 278, 183-185.
29. 2-adrenoceptor antagonists on extracellular dopamine concentrations in rat striatum. In: Noradrenergic Mechanisms in Parkinson's Disease, pp. 159-172. Eds. M. Briley & M. Marien. CRC Press.
30. NUTT, D.J., LALIES, M.D., HONE, L.A. & HUDSON, A.L. (1997). Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol., 11, 163-168.
31. 2-type receptors: pharmacological characterisation and relationship to monoamine oxidase. Br. J. Pharmacol., 109, 625-631.
32. ROBINSON, E.S.J., NUTT, D.J., JACKSON, H.C. & HUDSON, A.L. (1997). Antisense oligonucleotides in psychopharmacology and behaviour: promises and pitfalls. J. Psychopharmacol., 11, 259-269.
33. 2D-adrenoceptor in the rat. Br. J. Pharmacol., 125, 70P.
34. 2D-adrenoceptor in the rat. Br. J. Pharmacol., 128, 515-529.
35. ROSIN, D.L., ZENG, D., STORNETTA, R.L., NORTON, F.R., RILEY, T., OKUSA, M.D., GUYENET, P.G. & LYNCH, K.R. (1993). Immunohistochemical localization of alpha (2A)-adrenergic receptors in catecholaminergic and other brainstem neurons in the rat. Neurosci., 56, 139-155.
36. 2-adrenoceptor antagonist atipamezole. Anesthesiology, 3, 574-584.
37. STARKE, K. (1987). Presynaptic alpha-autoreceptors. Rev. Physiol. Biochem. Pharmacol., 107, 73-146.
38. 2A-adrenergic receptor-like immunoreactivity in the rat central nervous system. J. Comp. Neurol., 372, 111-134.
39. THOMAS, D.M. & HOLMANR,B. (1991). A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J. Neurochem., 56, 1741-1746.
40. 2-agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res. Rev., 7, 69-101.
41. 2-adrenergic receptor mRNAs in the rat CNS. Mol. Brain Res., 10, 219-225.